Senior Director, Advanced Pharmacometrics, Quantitative Pharmacology and Pharmacometrics – Immuno-Oncology (Hybrid or Remote)

We are seeking an accomplished scientific leader to join the Quantitative Pharmacology and Pharmacometrics – Immuno-Oncology (QP2-IO) team as Senior Director, Advanced Pharmacometrics. QP2-IO is part of the Global Clinical Development organization and is responsible for clinical pharmacology and pharmacometrics strategy and execution for oncology assets, from candidate nomination through registration.

About the role

The Senior Director will lead advanced pharmacometrics strategy and implementation to inform key oncology portfolio decisions. This individual will report directly to the Executive Director and Section Head, QP2-IO, and must have extensive experience in population PK/PD, tumor dynamics and survival modeling, Bayesian inference, and model-based meta-analysis (MBMA), along with strong cross-functional influencing skills in a matrixed environment. The role includes substantial internal and external engagement, including with vendors and regulatory agencies.

Responsibilities

• Strategic Leadership
  • Lead quantitative pharmacology strategy across the oncology portfolio, ensuring alignment with program goals and organizational priorities.
  • Develop and implement long-range plans for integrating MIDD, pharmacometrics, data science, and Bayesian modeling approaches to accelerate and de-risk oncology drug development.
  • Partner with senior leaders in Clinical Development, Translational Medicine, Biostatistics, Regulatory, and Data Science to define modeling strategies that influence program design and key decisions.
• Scientific & Technical Leadership
  • Oversee development of advanced pharmacometrics modeling including population PK/PD, tumor dynamics and survival modeling, advanced models to inform dose selection, clinical design, and benefit–risk assessments.
  • Champion the use of Bayesian methods including hierarchical and joint modeling, and prior-data integration to strengthen oncology decision-making.
  • Ensure high-quality, regulatory grade pharmacometric deliverables for submissions, label negotiations, and scientific advice meetings.
  • Stay at the forefront of emerging methodologies including AI/ML and promote innovation in modeling tools, computational frameworks, and analytics platforms.
• Team Leadership & Development
  • Lead, mentor, and develop a team of quantitative scientists in a matrixed role.
  • Foster a culture of scientific rigor, excellence, collaboration, and innovation.
• Cross-Functional Collaboration
  • Collaborate with QP2 leads to design efficient, model-informed clinical trials.
  • Work closely with Translational, Clinical, and Biostatistics functions to integrate advanced modeling into decision frameworks.
• Regulatory & External Engagement
  • Contribute to regulatory strategy through preparation of pharmacometric reports, briefing documents, and presentations.
  • Represent the company at scientific conferences, external collaborations, consortia, and industry working groups.

Qualifications

• Ph.D. in pharmacokinetics/pharmacodynamics, pharmacometrics, mathematics, statistics/biostatistics, chemical/biomedical engineering, or a related discipline with at least 10 years of pharmaceutical drug development experience, including substantial experience in pharmacometrics roles.
• OR Master’s, PharmD, or equivalent degree with at least 15 years of pharmaceutical drug development experience, with a demonstrated record of increasing responsibility, independence, and leadership in similar roles.

Skills

• Extensive and in-depth experience in application of MIDD in oncology drug development to drive impactful development decisions.
• Deep proficiency in advanced pharmacometrics methods such as:
  • Bayesian hierarchical models, joint models of tumor and survival, drop-out models, MBMA, advanced clinical trial simulation methods, integrating PROs and RWD into traditional NLME approaches.
• Hands-on experience with software such as NONMEM, Pumas, Stan, R, and/or other Bayesian platforms.
• Advanced analytical skills, including designing and interpreting clinical trials, problem solving, critical data analysis, interpretation, and decision making.
• Understanding of oncology biology, translational pathways, and clinical endpoints (e.g., ORR, PFS, OS, tumor dynamic modeling).
• Demonstrated impact across multiple therapeutic modalities, including antibody–drug conjugates (ADCs), T cell engagers (TCEs), monoclonal antibodies (mAbs), cytokines, and small molecules.
• Experience integrating AI/ML methods into clinical pharmacology and pharmacometrics workflows to advance model-informed drug development, optimize study design, and support regulatory decision-making is preferred.
• Excellent written and verbal communication skills, with a track record of effective cross-functional collaboration, stakeholder management in a matrixed environment, and ability to influence at senior levels.

Pay

The salary range for this role is $210,400.00 - $331,100.00. An employee’s position within the salary range will be based on several factors including, but not limited to relevant education, qualifications, certifications, experience, skills, geographic location, government requirements, and business or organizational needs. The successful candidate will be eligible for annual bonus and long-term incentive, if applicable.

Benefits

We offer a comprehensive package of benefits. Available benefits include medical, dental, vision healthcare and other insurance benefits (for employee and family), retirement benefits, including 401(k), paid holidays, vacation, and compassionate and sick days. More information about benefits is available at Merck Benefits.

Schedule

• The remote position is only applicable for those that are not within commutable distance to primary sites noted in posting. If commutable, the position will be hybrid.
• Travel Requirements: 10%